Hans-Peter Hasler is a Swiss businessperson who founded Vicarius Pharma AG and who has been at the head of 7 different companies. Mr. Hasler is Non-Executive Chairman at Shield Therapeutics Plc, Chairman of Medical Imaging Analysis Center and Chairman for HBM Healthcare Investments AG.
He is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA, Vicarius Pharma AG (former Chief Executive Officer & Director) and Gain Therapeutics, Inc. and Principal at Hph Management GmbH.
In the past he was Managing Director at Wyeth-lederle Pharma GmbH, COO, EVP, Head-Global Neurology & International at Biogen, Inc. Chief Operating Officer of Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer at Elan Corp. Plc, Chief Marketing Officer of Wyeth Corp. and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC.
Mr. Hasler received an undergraduate degree from Schweizerisches Institut fŘr Betriebs÷konomie AG.